Effect of Pirenoxine Ophthalmic Solution on Senile Incipient Cataract in Dogs

DOI JASI Web Site

Bibliographic Information

Other Title
  • 犬の老年性初発白内障に対するピレノキシン点眼剤の効果
  • イヌ ノ ロウネンセイ ショハツ ハクナイショウ ニ タイスル ピレノキシン

Search this article

Description

Pirenoxine ophthalmic solution, an anticataract drug for human use, was tested for its effectiveness in the treatment of senile incipient cataract in dogs. Of 18 cases treated with the drug, 13 (72.2%) cases responded favorably resulting in improved lens opacity or delayed progress of the disease. Hyperemia and epiphora, both being local sensitive symptoms, were obsereved in one case. Improved lens opacity was noticeable after medication for 81.6 days on average, and the effect was pronounced in younger cases with cortical cata-ract.

Journal

Keywords

Details 詳細情報について

Report a problem

Back to top